GlassScriptPhysician profile
Alexandra Darien
NPI 1003431198
$5,705.19
in general payments reported to CMS, 2019-2025
9 companies · $3,032 in 2025
The $3,032 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $1,836 · 2023: $431 · 2024: $303 · 2025: $3,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,952 · Travel and Lodging: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.90 |
| Travel and Lodging | $813.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,634.41 | 2022-2025 | Titan |
| Boston Scientific Corporation | $2,384.60 | 2021-2025 | Ams 700, General - Kidney Stone Disease, Ams 700 Cxr Rte Kit |
| Endo USA, INC. | $263.37 | 2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $137.55 | 2023 | Xiaflex |
| Medtronic, INC. | $101.31 | 2023 | Interstim |
| Axonics, INC. | $62.07 | 2021-2023 | Axonics |
| Procept Biorobotics Corporation | $54.17 | 2025 | |
| Urogen Pharma, INC. | $48.73 | 2024 | |
| Teleflex LLC | $18.98 | 2023 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Darien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.